Skip to main content
. 2016 May 3;44(6):707–712. doi: 10.1007/s15010-016-0899-6

Table 1.

Patient characteristics

Alcohol/BAC Alcohol/OCT
CVC EC CVC EC
Number of patients 29 30 25 26
Catheter insertion sites 26/0/3 16/10/4 23/1/1 10/14/2
(CVC: jugular vein/subclavian vein/no specification)
(EC: thoracical/lumbal/no specification)
Age (mean) 67.4 66.47 66.8 66,69
Sex (f/m) 12/17 14/16 15/10 11/15
BMI (mean) 25.2 26.15 27 27.7
Diabetes (y/n/not specified) 7/18/4 6/21/3 6/16/3 9/16/1
ASA-classification (I/II/III/IV/ not specified) 0/2/13/1/3 1/15/12/1/1 0/10/11/3/1 0/12/14/0/0
Allergy of any type (y/n/not specified) 4/21/4 6/23/1 6/18/1 7/19/0
Nicotine abuse (y/n/not specified) 9/16/4 12/17/1 5/18/2 3/21/2
Corticoid therapy (y/n/not specified) 3/22/4 0/30/0 3/22/0 1/24/1
Max. CRP (mean) 19 12.15 14.42 9.3
Max. white blood cells (mean) 10.6 12 13.01 9.35
Redness after treatment 2 2 2 1
Swelling after treatment 0 1 1 1